Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06914596 · ClinicalTrials.gov registry record · NA
A Clinical Trial Comparing Overnight and 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP
A NA study of Periodontitis (Stage 3), sponsored by McGuire Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 111
- Enrollment target
- 10
- Study locations
NCT06914596: Recruiting NA study of Periodontitis (Stage 3), sponsored by McGuire Institute.
NCT06914596 is a NA study of Periodontitis (Stage 3) that is actively recruiting participants, run by McGuire Institute. The registered enrollment target is 111 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 10 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06914596, a NA study of Periodontitis (Stage 3), is actively recruiting participants, sponsored by McGuire Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 111 participants
- Enrollment target
- 10
- Study locations
Study Summary
The goal of this clinical trial is to compare safety and to see if individuals with generalized stage III periodontitis that are given a periodontal hydrogel dressing on a wound healing after plaque and tartar have been removed from teeth have greater healing than individuals who are given no treatment after.
Primary Outcome
Change in Bleeding on Marginal Probing (BOMP) over time at 60 Days post non-surgical therapy
Conditions Studied
Interventions
- DEVICE Emanate Perio PODS
Study Locations (10)
Texas
- Perio Health Professionals - Houston
- Perio Health Professionals - Houston
- Periodontal Center of Excellence, PLLC - Spring
- Gulf Coast Periodontics - Victoria
California
- Regenerative Solutions - Fullerton
Connecticut
- Shoreline Periodontics and Dental Implants - New London
Massachusetts
- The Perio Studio - Boston
Nebraska
- Metro West Orthodontics & Periodontics - La Vista
Virginia
- Glazier Implants + Periodontics - Richmond
Washington
- Seattle Periodontist and Implant Dentistry - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2026-02-19 |
| Est. Completion | 2027-01-30 |
| Phase | NA |
What NCT06914596 shows while recruiting
NCT06914596 is an interventional study that assigns participants to a tested intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Periodontitis (Stage 3) appearing as the primary indexed condition, and to 1 intervention - of which Emanate Perio PODS is the first listed.
NCT06914596 lists 10 locations in 7 states (Texas, California, Connecticut).
Frequently Asked Questions
What is clinical trial NCT06914596 about?
NCT06914596 is a clinical study titled "A Clinical Trial Comparing Overnight and 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP". The goal of this clinical trial is to compare safety and to see if individuals with generalized stage III periodontitis that are given a periodontal hydrogel dressing on a wound healing after plaque and tartar have been removed from teeth have greater healing than individuals who are given no treatm...
What is the current status of trial NCT06914596?
This trial is currently recruiting. It is a NA study. The enrollment target is 111 participants. The study started on 2026-02-19. Estimated completion is 2027-01-30.
What conditions does trial NCT06914596 study?
This clinical trial studies the following conditions: Periodontitis (Stage 3).
What interventions are being tested in trial NCT06914596?
The interventions under investigation include: Emanate Perio PODS (DEVICE).
Who is sponsoring clinical trial NCT06914596?
This trial is sponsored by McGuire Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06914596 being conducted?
This trial has 10 study locations across California, Connecticut, Massachusetts, Nebraska, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06914596's enrollment target sits among peer trials
111 816th of 2000 higher than 1,185 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI